Advocacy Hub | CNSF Members
Updates & Recommendations |
|
from the Canadian League Against Epilepsy (CLAE) 16 April 2021 Oxcarbazepine Shortage Communication The Canadian League Against Epilepsy is currently working with Health Canada’s Drug Shortages Unit to determine the impact of Apotex and JAMP’s extended shortage on Oxcarbazepine supply. |
|
from the Canadian Stroke Consortium (CSC) 8 May 2021 What should we do as neurologists? Disseminate this information to your trainees, and neurology colleagues to spread awareness with respect to recognizing this entity and the distinct treatment strategy for this condition. |
